The success of copyright’s blockbuster initially drove a surge for the drug industry, however recent changes present a murky scenario for shareholders. Generic alternatives are eating into earnings, and continued https://lucytczw727719.buyoutblog.com/41219069/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-bet